Literature DB >> 8873664

Evidence for the existence of a functional cardiac renin-angiotensin system in humans.

G G Neri Serneri1, M Boddi, M Coppo, T Chechi, N Zarone, M Moira, L Poggesi, M Margheri, I Simonetti.   

Abstract

BACKGROUND: The presence of mRNA for the essential components of the renin-angiotensin system (RAS) has been found in animal and human hearts. The present study was designed to provide evidence for the existence of a (functional) cardiac RAS. METHODS AND
RESULTS: Twenty-four patients with atypical chest pain undergoing coronary angiography for diagnostic purposes were investigated. The cardiac production rate of angiotensins was estimated by measurement of the cardiac extraction of 125I-angiotensin I and 125I-angiotensin II associated with the determination of endogenous angiotensins in aortic and coronary sinus blood in normal, low, or high sodium diets. In a normal sodium diet, angiotensin I and II aorta-coronary sinus gradients were tendentially negative (-1.8 +/- 2.5 and -0.9 +/- 1.7 pg/mL, respectively), and the amounts of angiotensin I and II added by cardiac tissues were 6.5 +/- 3.1 and 2.7 +/- 1.3 pg/mL, respectively. The low sodium diet caused a significant increase in both plasma renin activity (PRA) and angiotensin I concentration in aortic but not in coronary sinus blood, resulting in a more negative aorta-coronary sinus gradient (-9.7 +/- 3.1 pg/mL, P < .01). Angiotensin formation by PRA in blood during transcardiac passage increased (P < .001), whereas angiotensin I formed by cardiac tissues decreased dramatically. Accordingly, in the low sodium diet, 125I-angiotensin II extraction did not change, the cardiac fractional conversion rate of 125I-angiotensin I to 125I-angiotensin II notably decreased (P < .01), and angiotensin II formation by cardiac tissues was undetectable. The high sodium diet caused a decrease in PRA and no changes in cardiac extraction of radiolabeled angiotensins; conversely, angiotensin I formed by cardiac tissues, cardiac Ang I fractional conversion rate, and angiotensin II formed during transcardiac passage significantly (P < .01 for all) increased.
CONCLUSIONS: These results provide evidence for the existence of a functional cardiac RAS independent of but related to the circulating RAS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8873664     DOI: 10.1161/01.cir.94.8.1886

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

Review 1.  Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin system.

Authors:  Alicia C Reid; Jacqueline A Brazin; Christopher Morrey; Randi B Silver; Roberto Levi
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

Review 2.  Imaging the renin-angiotensin- aldosterone system in the heart.

Authors:  Jamshid Shirani; Maria L Loredo; William C Eckelman; Elaine M Jagoda; Vasken Dilsizian
Journal:  Curr Heart Fail Rep       Date:  2005-08

3.  Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death.

Authors:  Hong D Xiao; Sebastien Fuchs; Duncan J Campbell; William Lewis; Samuel C Dudley; Vijaykumar S Kasi; Brian D Hoit; George Keshelava; Hui Zhao; Mario R Capecchi; Kenneth E Bernstein
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

Review 4.  Angiotensin converting enzyme 2: a new important player in the regulation of glycemia.

Authors:  Kavaljit H Chhabra; Harshita Chodavarapu; Eric Lazartigues
Journal:  IUBMB Life       Date:  2013-07-29       Impact factor: 3.885

Review 5.  Physiology, genetics, and cardiovascular disease: focus on African Americans.

Authors:  Gary H Gibbons
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-04       Impact factor: 3.738

Review 6.  Clinical perspectives and fundamental aspects of local cardiovascular and renal Renin-Angiotensin systems.

Authors:  Walmor C De Mello; Edward D Frohlich
Journal:  Front Endocrinol (Lausanne)       Date:  2014-02-19       Impact factor: 5.555

7.  Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ß/Fyn pathway.

Authors:  Ying Xin; Yang Bai; Xin Jiang; Shanshan Zhou; Yuehui Wang; Kupper A Wintergerst; Taixing Cui; Honglei Ji; Yi Tan; Lu Cai
Journal:  Redox Biol       Date:  2018-01-02       Impact factor: 11.799

Review 8.  Neurohormonal modulation in pulmonary arterial hypertension.

Authors:  Eva L Peters; Harm Jan Bogaard; Anton Vonk Noordegraaf; Frances S de Man
Journal:  Eur Respir J       Date:  2021-10-28       Impact factor: 16.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.